InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,234.40
(
0.01%
)
Dow Jones
39,872.99
(
0.17%
)
Brent Oil
81.78
(
-0.81%
)
Bitcoin
69,921.45
(
-0.30%
)
Post# of 251888
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119670
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: RNsidersbuying post# 251379

Wednesday, 04/03/2024 11:06:01 AM

Wednesday, April 03, 2024 11:06:01 AM

Post# of 251888
VNDA—Inasmuch as Iloperidone has been in clinical development for 20+ years, the composition-of-matter patent must have expired, so I presume that VNDA will only have the 3-year Hatch-Waxman exclusivity for new clinical investigation as protection from generic competition..

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up